A detailed history of Geode Capital Management, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 7,495,191 shares of TMO stock, worth $4.26 Billion. This represents 0.41% of its overall portfolio holdings.

Number of Shares
7,495,191
Previous 7,291,893 2.79%
Holding current value
$4.26 Billion
Previous $3.87 Billion 12.55%
% of portfolio
0.41%
Previous 0.41%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$528.82 - $599.43 $108 Million - $122 Million
203,298 Added 2.79%
7,495,191 $4.36 Billion
Q4 2023

Feb 13, 2024

BUY
$431.41 - $532.94 $74.9 Million - $92.5 Million
173,554 Added 2.44%
7,291,893 $3.87 Billion
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $69.5 Million - $80.1 Million
139,470 Added 2.0%
7,118,339 $3.6 Billion
Q2 2023

Aug 11, 2023

SELL
$508.46 - $591.13 $3.41 Million - $3.97 Million
-6,715 Reduced 0.1%
6,978,869 $3.64 Billion
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $56.8 Million - $64.3 Million
106,233 Added 1.54%
6,985,584 $4.03 Billion
Q4 2022

Feb 13, 2023

BUY
$484.71 - $571.37 $59.7 Million - $70.4 Million
123,256 Added 1.82%
6,879,351 $3.78 Billion
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $58.6 Million - $69.9 Million
115,628 Added 1.74%
6,756,095 $3.42 Billion
Q2 2022

Aug 12, 2022

BUY
$500.9 - $612.21 $49.6 Million - $60.6 Million
99,048 Added 1.51%
6,640,467 $3.6 Billion
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $72.1 Million - $88.8 Million
137,614 Added 2.15%
6,541,419 $3.85 Billion
Q4 2021

Feb 11, 2022

BUY
$569.0 - $667.24 $122 Million - $143 Million
214,375 Added 3.46%
6,403,805 $4.26 Billion
Q3 2021

Nov 12, 2021

BUY
$509.53 - $609.78 $60.8 Million - $72.8 Million
119,371 Added 1.97%
6,189,430 $3.53 Billion
Q2 2021

Aug 13, 2021

BUY
$441.0 - $508.24 $76.4 Million - $88 Million
173,240 Added 2.94%
6,070,059 $3.05 Billion
Q1 2021

May 12, 2021

BUY
$439.85 - $518.83 $41.3 Million - $48.7 Million
93,794 Added 1.62%
5,896,819 $2.68 Billion
Q4 2020

Feb 12, 2021

BUY
$435.06 - $527.66 $84.4 Million - $102 Million
193,906 Added 3.46%
5,803,025 $2.7 Billion
Q3 2020

Nov 13, 2020

BUY
$359.77 - $441.52 $26.4 Million - $32.4 Million
73,434 Added 1.33%
5,609,119 $2.47 Billion
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $20.9 Million - $27.6 Million
76,104 Added 1.39%
5,535,685 $2 Billion
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $20.8 Million - $27.7 Million
-81,340 Reduced 1.47%
5,459,581 $1.54 Billion
Q4 2019

Feb 13, 2020

BUY
$271.93 - $328.04 $41.2 Million - $49.7 Million
151,622 Added 2.81%
5,540,921 $1.8 Billion
Q3 2019

Nov 12, 2019

BUY
$268.46 - $305.43 $23.9 Million - $27.2 Million
89,130 Added 1.68%
5,389,299 $1.57 Billion
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $2.61 Million - $2.99 Million
10,130 Added 0.19%
5,300,169 $1.55 Billion
Q1 2019

May 14, 2019

BUY
$212.17 - $273.72 $83.2 Million - $107 Million
392,325 Added 8.01%
5,290,039 $1.45 Billion
Q4 2018

Feb 13, 2019

BUY
$208.47 - $251.98 $88.1 Million - $106 Million
422,625 Added 9.44%
4,897,714 $1.09 Billion
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $26 Million - $30.9 Million
126,552 Added 2.91%
4,475,089 $1.09 Billion
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $44.5 Million - $48.1 Million
219,072 Added 5.31%
4,348,537 $899 Million
Q1 2018

May 15, 2018

BUY
$192.98 - $224.11 $41 Million - $47.6 Million
212,244 Added 5.42%
4,129,465 $850 Million
Q4 2017

Feb 13, 2018

BUY
$182.03 - $200.37 $28.9 Million - $31.9 Million
158,961 Added 4.23%
3,917,221 $742 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $27 Million - $30.5 Million
157,011 Added 4.36%
3,758,260 $710 Million
Q2 2017

Aug 14, 2017

BUY
N/A
3,601,249
3,601,249 $627 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $223B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.